{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:20:57Z","timestamp":1790734857806,"version":"4.1.0"},"reference-count":25,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2018,12,17]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is a severe, progressive multiorgan disease but to date, there are no established standardised international guidelines for follow-up of patients with SSc. The goal of this project was to develop an expert consensus for annual systematic investigations in patients with SSc to enhance their standard-of-care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Material and methods<\/jats:title>\n                  <jats:p>The Delphi method was applied. All SSc experts from the European Scleroderma Trials and Research group network and the Scleroderma Clinical Trial Consortium were invited to participate. All experts were asked to answer questionnaires in five Delphi steps to determine the domains of interest and tools for each domain for an annual systematic assessment of patients with SSc. Each item was rated on a scale between 0% and 100% (not and very important), and parameters rated &gt;80% by more than 75% of the experts were regarded as acceptable.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 157 experts worldwide participated with 71.3% experts seeing &gt;50\u2009patients with SSc annually. In the first round, 23 domains and 204 tools were suggested. After five Delphi steps, experts agreed on 10 domains including (1) Raynaud\u2019s phenomenon; (2) Digital ulcers; (3) Skin and mucosa; (4) Lung; (5); Heart; (6) GI domain, (7) Renal; (8) Musculoskeletal; (9) Laboratory and (10) Treatment. Overall, 55 tools were identified including clinical assessments, laboratory measurements and imaging or functional investigations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Through five Delphi steps with world leading experts, a consensus was established on strongly suggested tools for a minimum annual systemic assessment of organ involvement in SSc. This work should enhance the standardisation and homogenisation of the practices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2018-000826","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T09:15:13Z","timestamp":1551690913000},"page":"e000826","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":49,"title":["Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-7422","authenticated-orcid":false,"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baron","family":"Murray","sequence":"additional","affiliation":[{"name":"Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otylia","family":"Kowal-Bielecka","sequence":"additional","affiliation":[{"name":"Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[{"name":"Rheumatology A Department, Universite Paris Descartes, Paris, France"},{"name":"INSERM U1016, Immunology, Cochin Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"2025090312112802000_5.1.e000826.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211448"},{"key":"2025090312112802000_5.1.e000826.2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2025090312112802000_5.1.e000826.3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2025090312112802000_5.1.e000826.4","doi-asserted-by":"crossref","unstructured":"Pattanaik D , Brown M , Postlethwaite BC , et al . Pathogenesis of systemic sclerosis. Front Immunol 2015;6.doi:10.3389\/fimmu.2015.00272","DOI":"10.3389\/fimmu.2015.00272"},{"key":"2025090312112802000_5.1.e000826.5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"The Lancet"},{"key":"2025090312112802000_5.1.e000826.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068"},{"key":"2025090312112802000_5.1.e000826.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2025090312112802000_5.1.e000826.8","unstructured":"Allanore Y , Denton C , Matucci-Cerinic M . Systemic Sclerosis. In: Bijlsma JWJ , ed. EULAR textbook on rheumatic diseases. In Press, 2012: 646\u2013567."},{"key":"2025090312112802000_5.1.e000826.9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","article-title":"Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group","volume":"57","author":"Jaeger","year":"2018","journal-title":"Rheumatology"},{"key":"2025090312112802000_5.1.e000826.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2025090312112802000_5.1.e000826.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230510"},{"key":"2025090312112802000_5.1.e000826.12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"2025090312112802000_5.1.e000826.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.23718"},{"key":"2025090312112802000_5.1.e000826.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.30541"},{"key":"2025090312112802000_5.1.e000826.15","doi-asserted-by":"publisher","DOI":"10.5301\/jsrd.5000231"},{"key":"2025090312112802000_5.1.e000826.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200742"},{"key":"2025090312112802000_5.1.e000826.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"key":"2025090312112802000_5.1.e000826.18","doi-asserted-by":"crossref","unstructured":"Adler S , Huscher D , Siegert E , et al . Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Res Ther 2018;20.doi:10.1186\/s13075-018-1517-z","DOI":"10.1186\/s13075-018-1517-z"},{"key":"2025090312112802000_5.1.e000826.19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5301\/jsrd.5000207","article-title":"Emerging strategies for treatment of systemic sclerosis","volume":"1","author":"Khanna","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"2025090312112802000_5.1.e000826.20","first-page":"75","article-title":"Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung Disease (SENSCIS\u2122)","volume":"35 Suppl 106","author":"Distler","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312112802000_5.1.e000826.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.im.2003.11.002"},{"key":"2025090312112802000_5.1.e000826.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.38172"},{"key":"2025090312112802000_5.1.e000826.23","first-page":"33","article-title":"Quality indicator set for systemic sclerosis","volume":"29","author":"Khanna","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312112802000_5.1.e000826.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"2025090312112802000_5.1.e000826.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174329","article-title":"Recommendations for patient engagement in guideline development panels: a qualitative focus group study of guideline-na\u00efve patients","volume":"12","author":"Armstrong","year":"2017","journal-title":"PLoS One"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2018-000826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:11:34Z","timestamp":1756926694000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2018-000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,4]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/rmdopen-2018-000826"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2018-000826","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}